Monte Financial Group, LLC Pfizer Inc Transaction History

Monte Financial Group, LLC

$270 Million
Q3 2025

A detailed history of Monte Financial Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Monte Financial Group, LLC holds 258,633 shares of PFE stock, worth $6.49 Million. This represents 2.44% of its overall portfolio holdings.

Number of Shares

258,633

Previous 230,500 12.21%

Holding current value

$6.49 Million

Previous $5.59 Million 17.93%

% of portfolio

2.44%

Previous 2.19%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	BUY	$23.29 - $25.88 $655,217 - $728,082	28,133 Added 12.21%	258,633 $6.59 Million
Q2 2025 Jul 23, 2025	SELL	$21.59 - $24.84 $465,631 - $535,724	-21,567 Reduced 8.56%	230,500 $5.59 Million
Q1 2025 Apr 22, 2025	BUY	$25.01 - $27.13 $1.09 Million - $1.19 Million	43,740 Added 21.0%	252,067 $6.39 Million
Q4 2024 Jan 21, 2025	BUY	$24.8 - $30.19 $319,498 - $388,937	12,883 Added 6.59%	208,327 $5.53 Million
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $177,750 - $201,429	-6,417 Reduced 3.18%	195,444 $5.66 Million

Q2 2024 Jul 22, 2024	BUY	$25.26 - $29.6 $332,017 - $389,062	13,144 Added 6.96%	201,861 $5.65 Million
Q1 2024 Apr 29, 2024	BUY	$25.89 - $29.73 $620,868 - $712,955	23,981 Added 14.56%	188,717 $5.24 Million
Q4 2023 Jan 22, 2024	BUY	$26.13 - $33.94 $653,276 - $848,533	25,001 Added 17.89%	164,736 $4.74 Million
Q3 2023 Oct 24, 2023	BUY	$32.09 - $37.51 $336,656 - $393,517	10,491 Added 8.12%	139,735 $4.64 Million
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $472,160 - $546,278	13,072 Added 11.25%	129,244 $4.74 Million
Q1 2023 Apr 26, 2023	BUY	$39.39 - $51.28 $241,224 - $314,038	6,124 Added 5.56%	116,172 $4.74 Million
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $129,550 - $169,113	3,103 Added 2.9%	110,048 $0
Q3 2022 Oct 24, 2022	BUY	$43.76 - $53.42 $127,210 - $155,291	2,907 Added 2.79%	106,945 $4.68 Million
Q2 2022 Jul 20, 2022	BUY	$46.53 - $55.17 $11,306 - $13,406	243 Added 0.23%	104,038 $5.46 Million
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $716,856 - $888,275	-15,669 Reduced 13.12%	103,795 $5.37 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $136,727 - $202,676	-3,309 Reduced 2.7%	119,464 $7.05 Million
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $202,294 - $259,864	-5,154 Reduced 4.03%	122,773 $5.28 Million
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $18,637 - $21,112	519 Added 0.41%	127,927 $5.01 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $646,423 - $729,036	19,302 Added 17.85%	127,408 $4.62 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $49,067 - $62,392	1,466 Added 1.37%	108,106 $3.98 Million
Q3 2020 Nov 03, 2020	SELL	$31.75 - $37.25 $110,712 - $129,890	-3,487 Reduced 3.17%	106,640 $3.91 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $504,178 - $611,643	16,739 Added 17.92%	110,127 $3.6 Million
Q1 2020 Apr 28, 2020	BUY	$27.03 - $38.62 $2.13 Million - $3.04 Million	78,816 Added 540.87%	93,388 $3.05 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $6,913 - $7,845	-210 Reduced 1.42%	14,572 $571,000
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $10,624 - $13,776	-327 Reduced 2.16%	14,782 $531,000
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $47,001 - $52,771	-1,271 Reduced 7.76%	15,109 $655,000
Q4 2018 Jan 31, 2019	BUY	$38.47 - $43.86 $11,464 - $13,070	298 Added 1.85%	16,380 $715,000
Q3 2018 Oct 16, 2018	SELL	$34.47 - $41.81 $135,018 - $163,769	-3,917 Reduced 19.59%	16,082 $709,000
Q2 2018 Oct 16, 2018	SELL	$32.98 - $35.16 $55,175 - $58,822	-1,673 Reduced 7.72%	19,999 $726,000
Q1 2018 Oct 16, 2018	SELL	$31.91 - $37.02 $3,191 - $3,702	-100 Reduced 0.46%	21,672 $769,000
Q4 2017 Oct 16, 2018	BUY	$33.26 - $35.29 $724,136 - $768,333	21,772	21,772 $789,000

Others Institutions Holding PFE

# of Institutions

3,356

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monte Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monte Financial Group, LLC with notifications on news.

Account

Monte Financial Group, LLC Pfizer Inc Transaction History